Increased Pollution Exposure Ups Health Care Visits for Acute URI

Share this content:
Increased Pollution Exposure Ups Health Care Visits for Acute URI
Increased Pollution Exposure Ups Health Care Visits for Acute URI

MONDAY, April 16, 2018 (HealthDay News) -- Short-term exposure to fine particulate matter (PM2.5) is associated with increased health care utilization for acute lower respiratory infection (ALRI), according to a study published online April 13 in the American Journal of Respiratory and Critical Care Medicine.

Benjamin D. Horne, Ph.D., M.P.H., from the Intermountain Medical Center Heart Institute in Salt Lake City, and colleagues examined the correlation between ambient PM2.5 levels and health care encounters for ALRI in an observational case-crossover study. A total of 146,397 subjects were studied if they had an ALRI diagnosis. PM2.5 air pollution concentrations were measured between 1999 and 2016; after stratification by ages, odds ratios for ALRI health care encounters were calculated.

The researchers found that the odds of ALRI encounter for the 112,467 subjects aged 0 to 2 years of age increased within one week of elevated PM2.5, and peaked after three weeks, with a cumulative 28-day odds ratio of 1.15 per +10 µg/m³. Following elevated ambient PM2.5 levels, ALRI encounters with diagnosed and laboratory-confirmed respiratory syncytial virus and influenza increased. Older children had similar elevated odds for ALRI, although the number of events and precision of estimates were much lower.

"Short-term exposure to elevated PM2.5 air pollution was associated with greater health care utilization for ALRI in both young children, older children, and adults," the authors write. "Further exploration is needed of causal interactions between PM2.5 and ALRI."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »